Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ningning Cheng, Nan Jiang, Yuanhui Fu, Zhuxin Xu, Xianglei Peng, Jiemei Yu, Shan Cen, Yucheng Wang, Guoning Zhang, Yanpeng Zheng & Jinsheng He. (2022) The mechanism and pharmacodynamics of 2-((1H-indol-3-yl)thio/sulfinyl)-N-pheny acetamide derivative as a novel inhibitor against human respiratory syncytial virus. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 2598-2604.
Read now
Read now
Marwa Ghazaly & Simon Nadel. (2018) Overview of prevention and management of acute bronchiolitis due to respiratory syncytial virus. Expert Review of Anti-infective Therapy 16:12, pages 913-928.
Read now
Read now
Farnoosh Tayyari & Richard G Hegele. (2012) Identifying targets in the hunt for effective respiratory syncytial virus interventions. Expert Review of Respiratory Medicine 6:2, pages 215-222.
Read now
Read now
Leonard R Krilov. (2011) Respiratory syncytial virus disease: update on treatment and prevention. Expert Review of Anti-infective Therapy 9:1, pages 27-32.
Read now
Read now
Articles from other publishers (34)
Wei Chen, Yi-Hsiang Chen, Ya-Chun Liao, Xin-Wen Huang, Ting-Jang Lu & Shin-Ru Shih. (2023) Effect of hot water extracts of Arthrospira maxima (spirulina) against respiratory syncytial virus. Phytomedicine 110, pages 154611.
Crossref
Crossref
Delphyne Descamps, Andressa Peres de Oliveira, Lorène Gonnin, Sarah Madrières, Jenna Fix, Carole Drajac, Quentin Marquant, Edwige Bouguyon, Vincent Pietralunga, Hidekatsu Iha, Armando Morais Ventura, Frédéric Tangy, Pierre-Olivier Vidalain, Jean-François Eléouët & Marie Galloux. (2021) Depletion of TAX1BP1 Amplifies Innate Immune Responses during Respiratory Syncytial Virus Infection. Journal of Virology 95:22.
Crossref
Crossref
Monika Bajorek, Marie Galloux, Charles-Adrien Richard, Or Szekely, Rina Rosenzweig, Christina Sizun & Jean-Francois Eleouet. (2021) Tetramerization of Phosphoprotein Is Essential for Respiratory Syncytial Virus Budding while Its N-Terminal Region Mediates Direct Interactions with the Matrix Protein. Journal of Virology 95:7.
Crossref
Crossref
Maxence Frétaud, Delphyne Descamps, Daphné Laubreton, Marie-Anne Rameix-Welti, Jean-François Eléouët, Thibaut Larcher, Marie Galloux & Christelle Langevin. (2021) New Look at RSV Infection: Tissue Clearing and 3D Imaging of the Entire Mouse Lung at Cellular Resolution. Viruses 13:2, pages 201.
Crossref
Crossref
Jorge A. Soto, Nicolás M. S. Gálvez, Gaspar A. Pacheco, Susan M. Bueno & Alexis M. Kalergis. (2020) Antibody development for preventing the human respiratory syncytial virus pathology. Molecular Medicine 26:1.
Crossref
Crossref
Marie Galloux, Nadège Gsponer, Vanessa Gaillard, Brice Fenner, Thibaut Larcher, Marthe Vilotte, Julie Rivière, Charles-Adrien Richard, Jean-François Eléouët, Ronan Le Goffic, Joelle Mettier & Origène Nyanguile. (2020)
Targeting the Respiratory Syncytial Virus N
0
-P Complex with Constrained α-Helical Peptides in Cells and Mice
. Antimicrobial Agents and Chemotherapy 64:10.
Crossref
Crossref
Anthony J. Hickey. (2020) Emerging trends in inhaled drug delivery. Advanced Drug Delivery Reviews 157, pages 63-70.
Crossref
Crossref
Origène Nyanguile. (2019) Peptide Antiviral Strategies as an Alternative to Treat Lower Respiratory Viral Infections. Frontiers in Immunology 10.
Crossref
Crossref
Wei Tang, Manmei Li, Yujun Liu, Ning Liang, Zhu Yang, Yanxiang Zhao, Shuai Wu, Sangwei Lu, Yaolan Li & Fenyong Liu. (2018) Small molecule inhibits respiratory syncytial virus entry and infection by blocking the interaction of the viral fusion protein with the cell membrane. The FASEB Journal 33:3, pages 4287-4299.
Crossref
Crossref
Stephanie N. Hicks, Supranee Chaiwatpongsakorn, Heather M. Costello, Jason S. McLellan, William Ray & Mark E. Peeples. (2018)
Five Residues in the Apical Loop of the Respiratory Syncytial Virus Fusion Protein F
2
Subunit Are Critical for Its Fusion Activity
. Journal of Virology 92:15.
Crossref
Crossref
Bob Meek, Marcel P. H. van den Broek & Anouk C. M. Platteel. (2018) Biologicals: spectrum en targets. Bijblijven 34:2, pages 93-107.
Crossref
Crossref
Antonina A. Fedorova, Elena P. Goncharova, Lyudmila S. Koroleva, Ekatherina A. Burakova, Elena I. Ryabchikova, Elena V. Bichenkova, Vladimir N. Silnikov, Valentin V. Vlassov & Marina A. Zenkova. (2016) Artificial ribonucleases inactivate a wide range of viruses using their ribonuclease, membranolytic, and chaotropic-like activities. Antiviral Research 133, pages 73-84.
Crossref
Crossref
Mohamed Ouizougun-Oubari, Nelson Pereira, Bogdan Tarus, Marie Galloux, Safa Lassoued, Jenna Fix, M. Alejandra Tortorici, Sylviane Hoos, Bruno Baron, Patrick England, Didier Desmaële, Patrick Couvreur, François Bontems, Félix A. Rey, Jean-François Eléouët, Christina Sizun, Anny Slama-Schwok & Stéphane Duquerroy. (2015) A Druggable Pocket at the Nucleocapsid/Phosphoprotein Interaction Site of Human Respiratory Syncytial Virus. Journal of Virology 89:21, pages 11129-11143.
Crossref
Crossref
Carrie W. Evans, Colm Atkins, Ashish Pathak, Brian E. Gilbert & James W. Noah. (2015) Benzimidazole analogs inhibit respiratory syncytial virus G protein function. Antiviral Research 121, pages 31-38.
Crossref
Crossref
Richard L. Mackman, Michael Sangi, David Sperandio, Jay P. Parrish, Eugene Eisenberg, Michel Perron, Hon Hui, Lijun Zhang, Dustin Siegel, Hai Yang, Oliver Saunders, Constantine Boojamra, Gary Lee, Dharmaraj Samuel, Kerim Babaoglu, Anne Carey, Brian E. Gilbert, Pedro A. Piedra, Robert Strickley, Quynh Iwata, Jaclyn Hayes, Kirsten Stray, April Kinkade, Dorothy Theodore, Robert Jordan, Manoj Desai & Tomas Cihlar. (2015) Discovery of an Oral Respiratory Syncytial Virus (RSV) Fusion Inhibitor (GS-5806) and Clinical Proof of Concept in a Human RSV Challenge Study. Journal of Medicinal Chemistry 58:4, pages 1630-1643.
Crossref
Crossref
Fred Y. Aoki. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
531
545.e5
.
Jannatul Firdous, Mohammad Ariful Islam, Sung-Moo Park, In-Su Cheon, Byoung-Shik Shim, Hyo-Shin Yoon, Manki Song, Jun Chang, Yun-Jaie Choi, Yeong-Min Park, Diana Boraschi, Seung-Hyun Han, Chong-Su Cho & Cheol-Heui Yun. (2014) Induction of long-term immunity against respiratory syncytial virus glycoprotein by an osmotic polymeric nanocarrier. Acta Biomaterialia 10:11, pages 4606-4617.
Crossref
Crossref
Clare L. Ross & Trevor T. Hansel. (2014) New Drug Therapies for COPD. Clinics in Chest Medicine 35:1, pages 219-239.
Crossref
Crossref
Michiel L. Houben, Marloes J. M. Olde Nordkamp, Peter G. J. Nikkels, Cornelis K. van der Ent, Linde Meyaard & Louis Bont. (2013) Soluble Leukocyte-Associated Ig-Like Receptor-1 in Amniotic Fluid Is of Fetal Origin and Positively Associates with Lung Compliance. PLoS ONE 8:12, pages e83920.
Crossref
Crossref
Amy R. Simon, Verena Karsten, Rachel Meyers, Jeff Cehelsky, Jared Gollob, Akshay Vaishnaw & Sara Nochur. 2013. RNA Interference from Biology to Therapeutics. RNA Interference from Biology to Therapeutics
315
328
.
Maximillian S. Habibi & Peter J.M. Openshaw. (2012) Benefit and harm from immunity to respiratory syncytial virus. Current Opinion in Infectious Diseases 25:6, pages 687-694.
Crossref
Crossref
Rachel J. Derscheid & Mark R. Ackermann. (2012) Perinatal Lamb Model of Respiratory Syncytial Virus (RSV) Infection. Viruses 4:10, pages 2359-2378.
Crossref
Crossref
Nicholas A. Meanwell & David R. Langley. 2012. Protein-Protein Interactions. Protein-Protein Interactions
167
196
.
Sadie J. Ryan & Peter D. Walsh. (2011) Consequences of Non-Intervention for Infectious Disease in African Great Apes. PLoS ONE 6:12, pages e29030.
Crossref
Crossref
Virginie Dubosclard, Marie-Lise Blondot, Jean-François Eléouët, François Bontems & Christina Sizun. (2011) 1H, 13C, and 15N resonance assignment of the central domain of hRSV transcription antitermination factor M2-1. Biomolecular NMR Assignments 5:2, pages 237-239.
Crossref
Crossref
Farnoosh Tayyari, David Marchant, Theo J Moraes, Wenming Duan, Peter Mastrangelo & Richard G Hegele. (2011) Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nature Medicine 17:9, pages 1132-1135.
Crossref
Crossref
Soraya Utokaparch, David Marchant, John V. Gosselink, John E. McDonough, Eva E. Thomas, James C. Hogg & Richard G. Hegele. (2011) The Relationship Between Respiratory Viral Loads and Diagnosis in Children Presenting to a Pediatric Hospital Emergency Department. Pediatric Infectious Disease Journal 30:2, pages e18-e23.
Crossref
Crossref
Hector C. Aguilar & Benhur Lee. (2011) Emerging paramyxoviruses: molecular mechanisms and antiviral strategies. Expert Reviews in Molecular Medicine 13.
Crossref
Crossref
Stanislaw J. Gabryszewski, Ofir Bachar, Kimberly D. Dyer, Caroline M. Percopo, Kristin E. Killoran, Joseph B. Domachowske & Helene F. Rosenberg. (2011)
Lactobacillus
-Mediated Priming of the Respiratory Mucosa Protects against Lethal Pneumovirus Infection
. The Journal of Immunology 186:2, pages 1151-1161.
Crossref
Crossref
Michiel L. HoubenLouis BontBerry Wilbrink, Mirjam E. BelderbosJan L. L. KimpenGerard H. A. Visser & Maroeska M. Rovers. (2011) Clinical Prediction Rule for RSV Bronchiolitis in Healthy Newborns: Prognostic Birth Cohort Study. Pediatrics 127:1, pages 35-41.
Crossref
Crossref
Dirk Roymans & Anil Koul. (2010) Respiratory syncytial virus: a prioritized or neglected target?. Future Medicinal Chemistry 2:10, pages 1523-1527.
Crossref
Crossref
John S. Tregoning & Jürgen Schwarze. (2010) Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and Immunology. Clinical Microbiology Reviews 23:1, pages 74-98.
Crossref
Crossref
Shane Storey. (2010) Respiratory syncytial virus market. Nature Reviews Drug Discovery 9:1, pages 15-16.
Crossref
Crossref
Trevor T Hansel & Peter J Barnes. (2009) New drugs for exacerbations of chronic obstructive pulmonary disease. The Lancet 374:9691, pages 744-755.
Crossref
Crossref